§ Helen JonesTo ask the Secretary of State for Health how many MRSA cases were reported by each acute trust in each year since 1997. [129687]
Lead researcher Project title Project end date Professor Michael R.W. Brown. Department of Pharmacy and Pharmacology. University of Bath Dormancy, resistance to antimicrobials and environmental survival. March 2006 Dr. Mark H. Wilcox, Department of Microbiology. Leeds University What is the size and nature of the current need for single room isolation in hospital and how does success or failure to isolate patients affect the control of MRSA? May 2005 Dr. Alasdair MacGowan, Department of Medical Microbiology, Southmead Hospital The development and evaluation of a population-based surveillance programme for antimicrobial resistance. June 2006 Dr. Lucinda M.C. Hall. Department of Microbiology, Barts and The London School of Medicine and Dentistry Mechanisms involved in the maintenance of antibiotic resistance. September 2006 Professor Robert J. Pratt, Richard Wells Research Centre, Faculty of Health and Human Sciences, Thames Valley University Collaborative research to reduce the incidence of hospital ward-acquired MRSA colonisation/infection using statistical process control (SPC) feedback and structured diagnosis. February 2006 Dr. Stephanie Dancer, Scottish Centre for Infection and Environmental Health Environmental organisms from hospital wards with differing antibiotic exposure. December 2003 Professor Ian Chopra, Department of Microbiology, University of Leeds Emergence of resistance to linezolid in Staphylococcus aureus and evaluation of combination therapies to suppress resistance. April 2006 Dr. Jennifer A. Roberts, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine Faster testing for MRSA: models to estimate the cost-effectiveness of faster testing of cases admitted for hip and knee replacement. November 2004 Dr. Cliodna A.M. McNulty, PHLS Primary Care Unit. Gloucester Royal Hospital Household face-to-face survey of home held antibiotics and awareness of good antibiotic use. September 2004 Dr. David M. Livermore, ARMRL. Central Public Health Laboratory Does hypermutability underlie the rapid clinical emergence of resistant mutant types that are vanishingly rare in vitro? May 2006 Dr. Andrew C. Hayward, UCL Centre for Infectious Disease Epidemiology Antimicrobial resistance and prescribing (AmRAP): sentinel surveillance using spotter practices—a feasibility study. March 2005 Dr. Andrew C. Hayward, UCL Centre for Infectious Disease Epidemiology Routine national surveillance of antibiotic prescribing for common infections using the GPRD and PACT data. June 2005 Dr. Anthony J. Howard, Department of Medical Microbiology and Public Health Laboratory. University Hospital of Wales Development of cost-effective surveillance for hospital antibiotic resistance and factors that contribute to its occurrence. March 2006